questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Troubles de la motricité
Syndromes parkinsoniens
Syndromes parkinsoniens : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndromes parkinsoniens : Questions médicales les plus fréquentes",
"headline": "Syndromes parkinsoniens : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndromes parkinsoniens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de la motricité",
"url": "https://questionsmedicales.fr/mesh/D009069",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de la motricité",
"code": {
"@type": "MedicalCode",
"code": "D009069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome parkinsonien secondaire",
"alternateName": "Parkinson Disease, Secondary",
"url": "https://questionsmedicales.fr/mesh/D010302",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome parkinsonien secondaire",
"code": {
"@type": "MedicalCode",
"code": "D010302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Parkinson post-encéphalitique",
"alternateName": "Parkinson Disease, Postencephalitic",
"url": "https://questionsmedicales.fr/mesh/D010301",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Parkinson post-encéphalitique",
"code": {
"@type": "MedicalCode",
"code": "D010301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens",
"alternateName": "Parkinsonian Disorders",
"code": {
"@type": "MedicalCode",
"code": "D020734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sara Hall",
"url": "https://questionsmedicales.fr/author/Sara%20Hall",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Shorena Janelidze",
"url": "https://questionsmedicales.fr/author/Shorena%20Janelidze",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Oskar Hansson",
"url": "https://questionsmedicales.fr/author/Oskar%20Hansson",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Hash Brown Taha",
"url": "https://questionsmedicales.fr/author/Hash%20Brown%20Taha",
"affiliation": {
"@type": "Organization",
"name": "Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Carlo Colosimo",
"url": "https://questionsmedicales.fr/author/Carlo%20Colosimo",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gut microbiota composition in colorectal cancer patients is genetically regulated.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35794137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-15230-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35768750",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12035-022-02934-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatoid prostatic carcinoma with adrenal metastasis and novel genetic alterations.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35765767",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/dc.25006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Refining Kidney Survival in 383 Genetically Characterized Patients With Nephronophthisis.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/36090483",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ekir.2022.05.035"
}
},
{
"@type": "ScholarlyArticle",
"name": "FUT2 gene as a genetic susceptible marker of infectious diseases: A Review.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35892094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles de la motricité",
"item": "https://questionsmedicales.fr/mesh/D009069"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndromes parkinsoniens",
"item": "https://questionsmedicales.fr/mesh/D020734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndromes parkinsoniens - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndromes parkinsoniens",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndromes parkinsoniens",
"description": "Comment diagnostiquer un syndrome parkinsonien ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on confondre avec d'autres maladies ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndromes parkinsoniens",
"description": "Quels sont les symptômes moteurs principaux ?\nQuels symptômes non moteurs sont fréquents ?\nComment évoluent les symptômes ?\nY a-t-il des symptômes précoces ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndromes parkinsoniens",
"description": "Peut-on prévenir les syndromes parkinsoniens ?\nQuel rôle joue l'exercice physique ?\nL'alimentation influence-t-elle le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe stress a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndromes parkinsoniens",
"description": "Quels sont les traitements médicamenteux ?\nLa chirurgie est-elle une option ?\nQuels sont les effets secondaires des médicaments ?\nY a-t-il des thérapies complémentaires ?\nComment gérer les symptômes non moteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndromes parkinsoniens",
"description": "Quelles sont les complications courantes ?\nComment les chutes affectent-elles les patients ?\nLes troubles cognitifs sont-ils fréquents ?\nQuelles sont les complications psychologiques ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndromes parkinsoniens",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur ?\nL'exposition professionnelle joue-t-elle un rôle ?\nY a-t-il des liens avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Genetic+Code&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un syndrome parkinsonien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes moteurs et non moteurs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM et des évaluations neuropsychologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la bradykinésie, la rigidité et les tremblements au repos."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Wilson ou des syndromes atypiques peuvent être confondues."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes moteurs principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes moteurs incluent la bradykinésie, la rigidité, et les tremblements."
}
},
{
"@type": "Question",
"name": "Quels symptômes non moteurs sont fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes non moteurs incluent la dépression, l'anxiété et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes évoluent progressivement, souvent en s'aggravant avec le temps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes précoces ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la perte de l'odorat ou des troubles du sommeil peuvent apparaître tôt."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent considérablement réduire la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les syndromes parkinsoniens ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé neurologique et retarder l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut réduire le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains pesticides et toxines peut augmenter le risque de Parkinson."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver les symptômes et influencer la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements médicamenteux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la lévodopa, les agonistes de la dopamine et les inhibiteurs de la COMT."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la stimulation cérébrale profonde peut être envisagée pour certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies complémentaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie et l'ergothérapie peuvent aider à améliorer la fonction motrice."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes non moteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements psychologiques et des médicaments peuvent aider à gérer les symptômes non moteurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les chutes, les troubles de la déglutition et les infections."
}
},
{
"@type": "Question",
"name": "Comment les chutes affectent-elles les patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chutes peuvent entraîner des blessures graves, comme des fractures, et réduire l'autonomie."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients développent des troubles cognitifs ou démence au cours de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent souffrir de dépression, d'anxiété et d'isolement social."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus susceptibles de développer des syndromes parkinsoniens."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des liens avec d'autres maladies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes et métaboliques peuvent être associées à un risque accru."
}
}
]
}
]
}
The risk of colorectal cancer (CRC) depends on environmental and genetic factors. Among environmental factors, an imbalance in the gut microbiota can increase CRC risk. Also, microbiota is influenced ...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) primarily affect the motor and frontotemporal areas of the brain, respectively. These disorders share clinical, genetic, and patho...
Hepatoid carcinoma (HC) encompasses epithelial extrahepatic tumors exhibiting features of hepatocellular carcinoma (HCC) both by morphology and immunohistochemistry. Distinguishing metastatic HCC from...
Nephronophthisis (NPH) comprises a group of rare disorders accounting for up to 10% of end-stage kidney disease (ESKD) in children. Prediction of kidney prognosis poses a major challenge. We assessed ...
Data was obtained from 3 independent sources, namely the network for early onset cystic kidney diseases clinical registry (...
A total of 383 individuals were available for analysis: 116...
The presented data will enable clinicians to better estimate kidney prognosis of distinct patients with NPH and thereby allow personalized counseling....
Some blood group antigens are reported as a susceptibility marker for some diseases. For instance, HBGA (Histo-blood group antigen) which is controlled by gene FUT2 also considered as a susceptible ma...
The food enzyme pullulanase (pullulan 6-α-glucanohydrolase, EC 3.2.1.41) is produced with the genetically modified...
The familial clustering phenomenon together with environmental influences indicates the presence of a genetic and epigenetic predisposition to systematic lupus erythematosus (SLE). Interestingly, rega...
Genetic and epigenetic alterations in LN include genes and noncoding RNAs that are involved in antigen-presenting, complements, immune cell infiltration, interferon pathways, and so on. Once genetic o...
Making additional checks for immunopathology-related heredity and epigenetic factors may lead to a more holistic perspective of LN....
The widely used paraben preservatives have been frequently detected in human urine, and shown to disrupt the endocrine system. Recently, several epidemiologic studies have investigated the association...
The capacity of plants to resist abiotic stresses is of great importance to agricultural, ecological and environmental sustainability, but little is known about its genetic underpinnings. Existing gen...
Posttranscriptional adenosine-to-inosine modifications amplify the functionality of RNA molecules in the brain, yet the cellular and genetic regulation of RNA editing is poorly described. We quantify ...